[HTML][HTML] The energetic cost of allostasis and allostatic load

N Bobba-Alves, RP Juster, M Picard - Psychoneuroendocrinology, 2022 - Elsevier
Chronic psychosocial stress increases disease risk and mortality, but the underlying
mechanisms remain largely unclear. Here we outline an energy-based model for the …

[HTML][HTML] Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury

WH Moos, DV Faller, IP Glavas, DN Harpp… - Biochemical …, 2022 - Elsevier
Pathological deterioration of mitochondrial function is increasingly linked with multiple
degenerative illnesses as a mediator of a wide range of neurologic and age-related chronic …

Gene therapy for mitochondrial diseases: Current status and future perspective

A Di Donfrancesco, G Massaro, I Di Meo, V Tiranti… - Pharmaceutics, 2022 - mdpi.com
Mitochondrial diseases (MDs) are a group of severe genetic disorders caused by mutations
in the nuclear or mitochondrial genome encoding proteins involved in the oxidative …

Trem2 expression in microglia is required to maintain normal neuronal bioenergetics during development

E Tagliatti, G Desiato, S Mancinelli, M Bizzotto… - Immunity, 2024 - cell.com
Triggering receptor expressed on myeloid cells 2 (Trem2) is a myeloid cell-specific gene
expressed in brain microglia, with variants that are associated with neurodegenerative …

As a potential therapeutic target, C1q induces synapse loss via inflammasome-activating apoptotic and mitochondria impairment mechanisms in Alzheimer's disease

PP Guan, TQ Ge, P Wang - Journal of Neuroimmune Pharmacology, 2023 - Springer
C1q, the initiator of the classical pathway of the complement system, is activated during
Alzheimer's disease (AD) development and progression and is especially associated with …

KLF2 regulates neural differentiation of dental pulp-derived stem cells by modulating autophagy and mitophagy

P Prateeksha, P Naidu, M Das, D Barthels… - Stem Cell Reviews and …, 2023 - Springer
Background Transplantation of stem cells for treating neurodegenerative disorders is a
promising future therapeutic approach. However, the molecular mechanism underlying the …

Effects of low dose ionizing radiation on the brain-a functional, cellular, and molecular perspective

RK Narasimhamurthy, KD Mumbrekar, BSS Rao - Toxicology, 2022 - Elsevier
Over the years, the advancement of radio diagnostic imaging tools and techniques has
radically improved the diagnosis of different pathophysiological conditions, accompanied by …

Modeling mitochondrial DNA diseases: from base editing to pluripotent stem‐cell‐derived organoids

I Tolle, V Tiranti, A Prigione - EMBO reports, 2023 - embopress.org
Mitochondrial DNA (mtDNA) diseases are multi‐systemic disorders caused by mutations
affecting a fraction or the entirety of mtDNA copies. Currently, there are no approved …

The role of mitochondria dysfunction in inflammatory bowel diseases and colorectal cancer

P Kłos, SA Dabravolski - International journal of molecular sciences, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is one of the leading gut chronic inflammation disorders,
especially prevalent in Western countries. Recent research suggests that mitochondria play …

The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease

HY Li, DS Liu, YB Zhang, H Rong, XJ Zhang - Biophysical Chemistry, 2023 - Elsevier
Parkinson's disease (PD) is an aging-associated neurodegenerative disorder with the
hallmark of abnormal aggregates of alpha-synuclein (α-syn) in Lewy bodies (LBs) and Lewy …